March 3, 2004 — Arrow International, headquartered in Reading, Pennsylvania, USA, develops, manufactures and markets a broad range of disposable catheters and related products for critical and cardiac care. Arrow’s critical care products are principally used for central venous access in the administration of fluids, drugs and blood products, as well as for patient monitoring, diagnosis and pain management. The company’s cardiac assist products are used in the diagnosis and treatment of patients with heart and vascular disease and to provide short-term cardiac assist following cardiac surgery, serious heart attack or balloon angioplasty. In fiscal 2003, Arrow’s revenue increased by 11.6% to US$380.4 million, while gross profits rose by 11.1% to US$190.1 million.

In the US, Arrow’s principal manufacturing site is the Reading facility, with other facilities located in Wyomissing, Pennsylvania; Asheboro, North Carolina; San Antonio, Texas; and Mount Holly, New Jersey. In addition, Arrow has manufacturing facilities in Mexico and the Czech Republic.

For a complete index of this report click on http://www.researchandmarkets.com/reports/45324

About Research and Markets Ltd.
Research and Markets Ltd. are Europe’s largest resource for market research. R&M distribute thousands of major research publications from the world’s leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com

Researchers at the National Institutes of Health (NIH) have found that more than 50 percent of the current asthma cases in the country can be attributed to allergies, with approximately 30 percent of those cases attributed to cat allergy.”It has towering been debated whether citizens who develop asthma have a genetic propensity to develop allergies, or atopy,” said Darryl C. Zeldin, M.D., a senior investigator at the National Institute of Environmental Health Sciences (NIEHS). [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

New clinical documents showed an experimental drug called pertuzumab prolonged the survival moment for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.The details was presented during a scientific session of the 14th European Cancer Conference held in Barcelona, Spain. The session’s main speaker was Sharmila Makhija, M.D., an associate professor in UAB’s Division of Gynecologic Oncology. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

A large observational study that tracked women from nine months prior to pregnancy through nine months after delivery has revealed that the number of women diagnosed with depression actually decreases slightly during pregnancy, next rises after delivery. The study additionally confirmed that many women who experience depression during pregnancy or the postpartum period have a history of earlier depression. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

People with heart disease should take special precautions before undergoing any kind of surgery, even noncardiac surgery, to reduce their risk of a cardiac event, according to new joint guidelines from the American College of Cardiology and the American Heart organization. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

UroToday.com- that essay published in the British Journal of Urology worldly by Georges-Pascal and Gill detail the oncologic findings and short-term recovery from laparoscopic radical cystectomy for clinically organ confined bladder cancer. The authors evaluated 37 patients who underwent laparoscopic radical cystectomy from 1999 to 2005. There was equal distribution of patients receiving a neobladder and an ileal conduit. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

UroToday.com- While laparoscopic partial nephrectomy (LPN) and laparoscopic radical nephrectomy (LRN) have been shown to be effective management in patients with localized renal tumor; there is limited goods on the expanded term effect on postoperative renal operate in these two patient groups. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today